Rossari Biotech Limited Cash Flow Conversion Efficiency
Rossari Biotech Limited cash flow conversion efficiency. Based on the latest financial reports, Rossari Biotech Limited (ROSSARI) has a cash flow conversion efficiency ratio of 0.031x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs302.28 Million ≈ $3.27 Million USD) by net assets (Rs9.78 Billion ≈ $105.80 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Rossari Biotech Limited (2017–2025)
Cash flow conversion efficiency of Rossari Biotech Limited from 2017 to 2025. This chart illustrates how Rossari Biotech Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View ROSSARI share price today for real-time trading data and today's change.
Rossari Biotech Limited Cash Flow Conversion Ratio Explained
Rossari Biotech Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Rossari Biotech Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Rossari Biotech Limited ranked by their cash flow conversion efficiency. Also see market cap of Rossari Biotech Limited for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
BROOGE ENERGY DL-0001
F:3SF
|
N/A |
|
Banvit Bandirma Vitaminli Yem Sanayi AS
IS:BANVT
|
-0.067x |
|
Transgene SA
PA:TNG
|
-0.152x |
|
Iljin HySolus Co Ltd
KO:271940
|
0.006x |
|
Steppe Gold Ltd
TO:STGO
|
0.135x |
|
Coincheck Group N.V. Ordinary Shares
NASDAQ:CNCK
|
-0.037x |
|
Chin Teck Plantations Bhd
KLSE:1929
|
0.015x |
|
TROOPS Inc
NASDAQ:TROO
|
-0.081x |
Annual Cash Flow Conversion Efficiency for Rossari Biotech Limited (2017–2025)
The table below shows the annual cash flow conversion efficiency of Rossari Biotech Limited from 2017 to 2025. Review Rossari Biotech Limited (ROSSARI) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs11.85 Billion ≈ $128.20 Million |
Rs1.37 Billion ≈ $14.86 Million |
0.116x | +180.84% |
| 2024-03-31 | Rs10.48 Billion ≈ $113.31 Million |
Rs432.55 Million ≈ $4.68 Million |
0.041x | -75.21% |
| 2023-03-31 | Rs9.15 Billion ≈ $98.97 Million |
Rs1.52 Billion ≈ $16.48 Million |
0.167x | +356.69% |
| 2022-03-31 | Rs8.05 Billion ≈ $87.08 Million |
Rs293.58 Million ≈ $3.17 Million |
0.036x | -68.80% |
| 2021-03-31 | Rs4.09 Billion ≈ $44.21 Million |
Rs477.67 Million ≈ $5.17 Million |
0.117x | -38.90% |
| 2020-03-31 | Rs2.87 Billion ≈ $31.00 Million |
Rs548.28 Million ≈ $5.93 Million |
0.191x | -66.73% |
| 2019-03-31 | Rs1.24 Billion ≈ $13.39 Million |
Rs711.77 Million ≈ $7.70 Million |
0.575x | +95.79% |
| 2018-03-31 | Rs870.80 Million ≈ $9.42 Million |
Rs255.69 Million ≈ $2.77 Million |
0.294x | +287.66% |
| 2017-03-31 | Rs619.85 Million ≈ $6.70 Million |
Rs46.95 Million ≈ $507.75K |
0.076x | -- |
About Rossari Biotech Limited
Rossari Biotech Limited manufactures and sells specialty chemicals in India and internationally. It offers soap and detergents; inks, paints, and coatings; ceramics and tiles; pulp and papers; cement; performance additives; and water treatment solutions. The company also provides textile specialty chemicals, such as cotton, polyester, acrylic, wool, silk, nylon, functional finishes, denim, printi… Read more